Search results :

NovoLog

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: A10AB05, A10AD05

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Hypoglycaemia postmarketing, 27% - 76% x x x x x x x x x
Influenza-like symptoms 2% - 13% x x
Headache 3% - 35% x x x x x x
Dyspepsia 6% - 9% x x
Hyporeflexia 7% - 11% x x
Sensory disturbance 7% - 9% x x
Onychomycosis 5% - 10% x x x
Urinary tract infection 7% - 8% x x x
Back pain 4% - 7% x x x
Nausea 5% - 7% x x x x x
Pharyngitis 2% - 7% x x
Abdominal pain 0% - 5% x x x x
Diarrhoea 2% - 8% x x x x
Rhinitis 2% - 12% x x
Upper respiratory tract infection postmarketing, 2% - 12% x x x
Bone pain 4% - 5% x x
Neuropathy rare, 2% - 8% x x x x x
Chest pain 3% - 5% x x
Skin disorder 2% - 5% x x
Sinusitis 1% - 5% x x x
Oedema uncommon x x x x x x x
Lipodystrophy uncommon x x x x x x x x x
Refraction disorder uncommon x x x x x
Swelling uncommon x x x
Urticaria uncommon x x x
Eruption uncommon x x x
Redness uncommon x x x
Rash very rare, uncommon x x x x x
Hypersensitivity very rare, uncommon x x x x x
Pruritus very rare, uncommon x x x x x
Diabetes mellitus postmarketing x
Type 2 diabetes mellitus postmarketing x
Neuropathy peripheral rare x x x x x x x
Hypoglycaemic episode postmarketing x
Anaphylactic shock very rare x x x
Angioedema very rare x x x
Palpitations very rare x x x
Sweating very rare x x x
Gastrointestinal tract irritation very rare x x x
Abortion spontaneous x
Abortion missed x
Anxiety x x
Arthralgia x
Asthenia x x x
Breech presentation x
Bronchitis x
Infection x
Confusional state x x
Connective tissue disorder x
Contusion x x x
Diabetic ketoacidosis x
Diabetic retinopathy x x
Drowsiness x x
Eye disorder x x x
Fatigue x x
Foetal death x
Gastrointestinal disorder x
Glycosuria x x x x
Hepatitis C x
Hunger x x
Hyperemesis gravidarum x
Hypernatraemia x x x x
Hypoglycaemic coma x
Immune system disorder x x x
Inflammation x x
Ketosis x
Premature labour x
Mediastinal disorder x
Nasal congestion x
Nasopharyngitis x
Nervous system disorder x x x
Nervousness x x
Pain x x
Pain in extremity x
Pneumothorax x
Pregnancy x
Retinal disorder x x x x x
Convulsion x x
Tonsillitis x
Tracheitis x
Tremor x x
Loss of consciousness x x
Uterine atony x
Viral infection x
Vomiting x
Weight increased x x x x
Gestational diabetes x
Oedema peripheral x x x x
Acute bronchitis x
Generalised oedema x
Injection site swelling x x
Injection site reaction x x x x
Ketonuria x
Malnutrition x x x
HELLP syndrome x
Unspecified disorder of skin and subcutaneous tissue x x x
Ketoacidosis x
Tachypnoea x
Cold sweat x x
Cerebration impaired x
Pallor of skin x x
Diabetic x
Hypoglycemic reaction x
Strangulation x
Obstetric procedure complication x
Infestation NOS x
Complication of delivery x
Worsening of diabetes x x x x x
Allergic skin reaction x
Lipohypertrophy x x x x x x
Lipoatrophy x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

insulin aspart

Side effects:24
Source:FDA Structured Product Label

INSULIN ASPART

Side effects:24
Source:FDA Structured Product Label

INSULIN ASPART

Side effects:24
Source:FDA Structured Product Label

INSULIN ASPART RECOMBINANT / NOVOLOG

Side effects:24
Source:FDA

INSULIN ASPART RECOMBINANT / NOVOLOG

Side effects:7
Source:FDA

INSULIN ASPART RECOMBINANT / NOVOLOG

Side effects:7
Source:FDA

insulin aspart / insulin aspart

Side effects:44
Source:EMA

insulin aspart / insulin aspart

Side effects:45
Source:EMA

INSULIN ASPART / NOVORAPID

Side effects:74
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label